Anthem Biosciences Limited — Quarterly Results & Earnings

₹656.25

+5.12%

Profit Growth YoY7.10%Latest quarter

Sales Growth YoY4.78%Latest quarter

Sales CAGR 5Y23.86%5 year compound

Profit CAGR 5Y37.27%5 year compound

📋

Quarterly Performance

YoY Profit Growth+7.10%

📈 Moderate growth

YoY Sales Growth+4.78%

📈 Moderate growth

OPM 5Y Average

Operating profit margin

38.78%

EPS Growth 5Y

-40.74%

Interest Coverage

Higher = safer debt servicing

63.42

ROE

20.83%

ROCE

28.50%

💡

Growth Analysis

Anthem Biosciences Limited reported YoY profit growth of 7.10% and revenue growth of 4.78% in the latest quarter. Positive profit growth shows business expansion. Over 5 years, sales compounded at 23.86% and profits at 37.27% annually. This is above-average growth for Indian listed companies. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Anthem Biosciences Limited

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Biotechnology Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.